Baxter International Inc. is a global medtech company. Its segments include Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. The Medical Products and Therapies segment includes sales of its sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant, and adhesion prevention products. The Healthcare Systems and Technologies segment includes sales of its connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices, and advanced equipment for the surgical space, including operating room integration technologies, precision positioning devices, and other accessories. The Pharmaceuticals segment includes sales of specialty injectable pharmaceuticals, inhaled anesthesia, and drug compounding. It provides a portfolio of diagnostic, critical care, nutrition, hospital and surgical products.
äŒæ¥ã³ãŒãBAX
äŒç€ŸåBaxter International Inc
äžå Žæ¥Jun 20, 2097
æé«çµå¶è²¬ä»»è
ãCEOãHider (Andrew P)
åŸæ¥å¡æ°38000
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Jun 20
æ¬ç€Ÿæåšå°One Baxter Parkway
éœåžDEERFIELD
蚌åžååŒæNASDAQ OMX NASDAQ Basic NYSE
åœUnited States of America
éµäŸ¿çªå·60015
é»è©±çªå·12249482000
ãŠã§ããµã€ãhttps://www.baxter.com/
äŒæ¥ã³ãŒãBAX
äžå Žæ¥Jun 20, 2097
æé«çµå¶è²¬ä»»è
ãCEOãHider (Andrew P)